DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 167 filers reported holding DIPLOMAT PHARMACY INC in Q3 2017. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $8,000 | -11.1% | 1,901 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $9,000 | -25.0% | 1,901 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $12,000 | +9.1% | 1,901 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $11,000 | -57.7% | 1,901 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $26,000 | -23.5% | 1,901 | +9.2% | 0.00% | 0.0% |
Q3 2018 | $34,000 | -15.0% | 1,741 | +10.3% | 0.00% | 0.0% |
Q2 2018 | $40,000 | +25.0% | 1,578 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $32,000 | +10.3% | 1,578 | +7.9% | 0.00% | 0.0% |
Q4 2017 | $29,000 | -23.7% | 1,462 | -20.5% | 0.00% | 0.0% |
Q3 2017 | $38,000 | +40.7% | 1,840 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $27,000 | -6.9% | 1,840 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $29,000 | +26.1% | 1,840 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $23,000 | -55.8% | 1,840 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $52,000 | -1.9% | 1,840 | +20.5% | 0.00% | 0.0% |
Q2 2016 | $53,000 | +39.5% | 1,527 | +9.9% | 0.00% | +33.3% |
Q1 2016 | $38,000 | – | 1,390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |